Imo, the biggest concern is cash flow problem. They have used...

Imo, the biggest concern is cash flow problem. They have used $3.5m in June 22 quarter, with cash balance of $2.29m at end of FY2022 which hopefully can last them for another quarter or max 2.

The question is, then what will be happening? Another capital raise? At what price would the shareholders buy?

I have been holding from 6 years ago, and picking more parcels all these years. But asking myself if I’m gonna buy more shares without knowing when the company is going to make real profit, the answer is NO! It’s too risky.

I’d hope that Pfizer’s offer would make other big players aware that this company has real value! In next 2-5 months, they will invest heavily to help the company with commercialisation. But in reality, the other big players would be just like Pfizer, they’d buy it out for the big potentials!

Then it makes me think, at the end of day, the company will be taken over. So for myself, the question is, at what price I am willing to vote Yes! Even though I see big value in this company, the reality is there!

just some thinking to share here. I haven’t decided to vote yes or no yet.